MedTrace Logo

Kuwait Heart Foundation Registry of Acute Coronary Events

NCT05857735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10812

Last updated 2025-08-20

No results posted yet for this study

Summary

Acute coronary syndrome (ACS) is the most common presentation of Coronary Artery Disease (CAD). It causes significant morbidity and mortality. The Gulf Registry of Acute Coronary Events (Gulf RACE) was conducted in 2007 and filled a wide gap in our understanding of ACS and its management in Kuwait and the Arabian Gulf region. However, the management of ACS has undergone tremendous advances over the last two decades involving pharmacotherapy and device therapy. Practice guidelines have also changed over the last decade. For example, in 2007, there was no catheterization laboratory in any of the general hospitals in Kuwait, primary percutaneous coronary intervention (PCI) was not being practiced, and the rate of in-hospital cardiac catheterization for all ACS patients was very low at around 10%. Currently, of the eight general hospitals in Kuwait, six have catheterization laboratories and five of the six serve as primary PCI centers. There is no contemporary ACS registry in Kuwait, studying its incidence, management, and influence of current changes in clinical practice on patients' outcomes. This multicentre disease-based, country-wide registry is guided by the American Heart Association policy statement for expanding the applications of existing and future clinical registries and the User's Guide published by the Agency for Health care Research and Quality guidance.

Conditions

  • ACS

Interventions

OTHER

Observational registry with no intervention.

No intervention

Sponsors & Collaborators

  • Servier

    collaborator INDUSTRY

  • Sanofi

    collaborator INDUSTRY

  • Beshara company

    collaborator UNKNOWN

  • Kuwait Heart Foundation

    collaborator UNKNOWN

  • Gulf Heart Association

    lead OTHER

Principal Investigators

  • Mohammad Zubaid, Professor · Kuwait University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2024-11-25
Completion
2025-06-30

Countries

  • Kuwait

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05857735 on ClinicalTrials.gov